Real-world comparative effectiveness of evolocumab versus ezetimibe in adults with atherosclerotic cardiovascular disease: an active-comparator new-user study
Authors:
- Nihar DesaiNDNihar Desai
- Ran JinRJRan Jin
- Kathleen HurwitzKHKathleen Hurwitz
- Nafeesa N. DhalwaniNDNafeesa N. Dhalwani
- Nuvan RathnayakaNRNuvan Rathnayaka
- Shia T. KentSKShia T. Kent
- Neil A. AccorttNANeil A. Accortt
- Timothy L. LashTLTimothy L. Lash
- Paul MuntnerPMPaul Muntner
- Chris P. GaleCGChris P. Gale
- Ann Marie NavarANAnn Marie Navar
- M. Alan BrookhartMBM. Alan Brookhart
Open Access
- 5 November 2026
- journal article
- Published by Elsevier in American Journal of Preventive Cardiology
Abstract
No abstract availableFunding Information
- Amgen
This publication has 26 references indexed in Scilit:
- Transparent Reporting of Observational Studies Emulating a Target Trial—The TARGET StatementJAMA, 2025
- Persistence and Adherence to PCSK9 Inhibitor Monoclonal Antibodies Versus Ezetimibe in Real-World SettingsAdvances in Therapy, 2024
- Staging and clean room: Constructs designed to facilitate transparency and reduce bias in comparative analyses of real‐world dataPharmacoepidemiology and Drug Safety, 2024
- Low-Density Lipoprotein Cholesterol Levels in Adults With Coronary Artery Disease in the US, January 2015 to March 2020JAMA, 2023
- A Comparison of Ezetimibe and Evolocumab for Atherogenic Lipid Reduction in Four Patient Populations: A Pooled Efficacy and Safety Analysis of Three Phase 3 StudiesCardiology and Therapy, 2020
- Development of algorithms for identifying fatal cardiovascular disease in Medicare claimsPharmacoepidemiology and Drug Safety, 2018
- Position matters: Validation of medicare hospital claims for myocardial infarction against medical record review in the atherosclerosis risk in communities studyPharmacoepidemiology and Drug Safety, 2018
- Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin IntoleranceJAMA, 2016
- Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studiesStatistics in Medicine, 2015
- Effect of Evolocumab or Ezetimibe Added to Moderate- or High-Intensity Statin Therapy on LDL-C Lowering in Patients With HypercholesterolemiaJAMA, 2014